Source: ERS Lung Science Conference 2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marcus Mall (Berlin, Germany). Microbiome in Cystic Fibrosis Exacerbations. ERS Lung Science Conference 2019

Member's Comments

No comment yet.

Related content which might interest you: Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Cystic Fibrosis in Iran Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 HspB5 in Cystic Fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Phenotypic Analysis of a Ferret Model of Cystic Fibrosis Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 Adaptation of prevotella during acute infectious pulmonary exacerbation Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ? Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Epidemiology of Idiopathic Pulmonary Fibrosis in Australia Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Impact of Anemia On Clinically Stable Adult Non-cystic Fibrosis Bronchiectasis Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Inflammatory biomarkers in urine of cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017. Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015